Therma Bright Inc (THRM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Therma Bright Inc (THRM) has a cash flow conversion efficiency ratio of 0.026x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-38.76K ≈ $-28.04K USD) by net assets (CA$-1.52 Million ≈ $-1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See THRM equity to assets ratio to measure how much of total assets are equity-financed.
Therma Bright Inc - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Therma Bright Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check THRM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Therma Bright Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Therma Bright Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Proven Vct PLC
LSE:PVN
|
-0.007x |
|
Ace Integrated Solutions Limited
NSE:ACEINTEG
|
0.021x |
|
Keystone Law Group PLC
LSE:KEYS
|
0.375x |
|
Orion Equities Ltd
AU:OEQ
|
-0.017x |
|
MOBILUM TECHNOLOGIES INC.
F:C0B
|
N/A |
|
Fountain Asset Corp
V:FA
|
0.119x |
|
Nexity Global SA
WAR:NXG
|
-0.001x |
|
Nextferm Technologies Ltd
TA:NXFR
|
N/A |
Annual Cash Flow Conversion Efficiency for Therma Bright Inc (2001–2025)
The table below shows the annual cash flow conversion efficiency of Therma Bright Inc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see THRM stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | CA$-1.57 Million ≈ $-1.13 Million |
CA$-146.53K ≈ $-106.00K |
0.094x | +112.28% |
| 2024-07-31 | CA$1.32 Million ≈ $958.00K |
CA$-1.01 Million ≈ $-730.10K |
-0.762x | +98.43% |
| 2023-07-31 | CA$44.79K ≈ $32.40K |
CA$-2.17 Million ≈ $-1.57 Million |
-48.555x | -3410.13% |
| 2022-07-31 | CA$2.75 Million ≈ $1.99 Million |
CA$-3.80 Million ≈ $-2.75 Million |
-1.383x | +36.29% |
| 2021-07-31 | CA$1.32 Million ≈ $951.41K |
CA$-2.86 Million ≈ $-2.07 Million |
-2.171x | -363.35% |
| 2020-07-31 | CA$223.97K ≈ $162.01K |
CA$-104.94K ≈ $-75.91K |
-0.469x | -170.73% |
| 2019-07-31 | CA$-286.40K ≈ $-207.18K |
CA$-189.72K ≈ $-137.24K |
0.662x | -86.82% |
| 2018-07-31 | CA$-71.59K ≈ $-51.79K |
CA$-359.89K ≈ $-260.34K |
5.027x | +2417.45% |
| 2017-07-31 | CA$-893.85K ≈ $-646.59K |
CA$-178.49K ≈ $-129.11K |
0.200x | +601500.19% |
| 2016-07-31 | CA$-1.63 Million ≈ $-1.18 Million |
CA$54.00 ≈ $39.06 |
0.000x | -100.22% |
| 2015-07-31 | CA$-1.42 Million ≈ $-1.03 Million |
CA$-21.43K ≈ $-15.50K |
0.015x | +50.83% |
| 2014-07-31 | CA$-5.52 Million ≈ $-3.99 Million |
CA$-55.16K ≈ $-39.90K |
0.010x | -33.21% |
| 2013-07-31 | CA$-5.62 Million ≈ $-4.06 Million |
CA$-84.10K ≈ $-60.84K |
0.015x | +22658.84% |
| 2012-07-31 | CA$-6.61 Million ≈ $-4.78 Million |
CA$-435.00 ≈ $-314.67 |
0.000x | -97.60% |
| 2011-07-31 | CA$-5.83 Million ≈ $-4.22 Million |
CA$-16.00K ≈ $-11.57K |
0.003x | -78.02% |
| 2009-07-31 | CA$-5.03 Million ≈ $-3.64 Million |
CA$-62.68K ≈ $-45.34K |
0.012x | -87.91% |
| 2008-07-31 | CA$-3.54 Million ≈ $-2.56 Million |
CA$-365.58K ≈ $-264.45K |
0.103x | -61.80% |
| 2007-07-31 | CA$-2.00 Million ≈ $-1.44 Million |
CA$-539.12K ≈ $-389.99K |
0.270x | -69.93% |
| 2006-07-31 | CA$-1.46 Million ≈ $-1.06 Million |
CA$-1.31 Million ≈ $-950.53K |
0.898x | +73.98% |
| 2005-07-31 | CA$-991.06K ≈ $-716.92K |
CA$-511.69K ≈ $-370.15K |
0.516x | -95.60% |
| 2004-07-31 | CA$-117.47K ≈ $-84.98K |
CA$-1.38 Million ≈ $-997.57K |
11.739x | +2050.43% |
| 2002-07-31 | CA$1.61 Million ≈ $1.16 Million |
CA$-968.11K ≈ $-700.31K |
-0.602x | +22.24% |
| 2001-07-31 | CA$633.46K ≈ $458.24K |
CA$-490.32K ≈ $-354.69K |
-0.774x | -- |
About Therma Bright Inc
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical he… Read more